Authors:
Mandic, R
Fackler, OT
Geyer, M
Linnemann, T
Zheng, YH
Peterlin, BM
Citation: R. Mandic et al., Negative factor from SIV binds to the catalytic subunit of the V-ATPase tointernalize CD4 and to increase viral infectivity, MOL BIOL CE, 12(2), 2001, pp. 463-473
Authors:
Fackler, OT
Wolf, D
Weber, HO
Laffert, B
D'Aloja, P
Schuler-Thurner, B
Geffin, R
Saksela, K
Geyer, M
Peterlin, BM
Schuler, G
Baur, AS
Citation: Ot. Fackler et al., A natural variability in the proline-rich motif of Nef modulates HIV-1 replication in primary T cells, CURR BIOL, 11(16), 2001, pp. 1294-1299
Citation: S. Kanazawa et Bm. Peterlin, Combinations of dominant-negative class II transactivator, p300 or CDK9 proteins block the expression of MHC II genes, INT IMMUNOL, 13(7), 2001, pp. 951-958
Authors:
Nekrep, N
Geyer, M
Jabrane-Ferrat, N
Peterlin, BM
Citation: N. Nekrep et al., Analysis of ankyrin repeats reveals how a single point mutation in RFXANK results in bare lymphocyte syndrome, MOL CELL B, 21(16), 2001, pp. 5566-5576
Authors:
Fackler, OT
d'Aloja, P
Baur, AS
Federico, M
Peterlin, BM
Citation: Ot. Fackler et al., Nef from human immunodeficiency virus type 1(F12) inhibits viral production and infectivity, J VIROLOGY, 75(14), 2001, pp. 6601-6608
Citation: M. Geyer et Bm. Peterlin, Domain assembly, surface accessibility and sequence conservation in full length HIV-1 Nef, FEBS LETTER, 496(2-3), 2001, pp. 91-95
Citation: S. Kanazawa et al., Tat competes with CIITA for the binding to P-TEFb and blocks the expression of MHC class II genes in HIV infection, IMMUNITY, 12(1), 2000, pp. 61-70
Citation: N. Nekrep et al., Mutations in the bare lymphocyte syndrome define critical steps in the assembly of the regulatory factor X complex, MOL CELL B, 20(12), 2000, pp. 4455-4461
Authors:
Okamoto, H
Cujec, TP
Okamoto, M
Peterlin, BM
Baba, M
Okamoto, T
Citation: H. Okamoto et al., Inhibition of the RNA-dependent transactivation and replication of human immunodeficiency virus type 1 by a fluoroquinoline derivative K-37, VIROLOGY, 272(2), 2000, pp. 402-408
Authors:
Okamoto, H
Cujec, TP
Peterlin, BM
Okamoto, T
Citation: H. Okamoto et al., HIV-1 replication is inhibited by a pseudo-substrate peptide that blocks Tat transactivation, VIROLOGY, 270(2), 2000, pp. 337-344
Authors:
Taube, R
Fujinaga, K
Irwin, D
Wimmer, J
Geyer, M
Peterlin, BM
Citation: R. Taube et al., Interactions between equine cyclin T1, Tat, and TAR are disrupted by a leucine-to-valine substitution found in human cyclin T1, J VIROLOGY, 74(2), 2000, pp. 892-898
Authors:
Barboric, M
Taube, R
Nekrep, N
Fujinaga, K
Peterlin, BM
Citation: M. Barboric et al., Binding of Tat to TAR and recruitment of positive transcription elongationfactor b occur independently in bovine immunodeficiency virus, J VIROLOGY, 74(13), 2000, pp. 6039-6044
Authors:
Liu, LX
Heveker, N
Fackler, OT
Arold, S
Le Gall, S
Janvier, K
Peterlin, BM
Dumas, C
Schwartz, O
Benichou, S
Benarous, R
Citation: Lx. Liu et al., Mutation of a conserved residue (D123) required for oligomerization of human immunodeficiency virus type 1 Nef protein abolishes interaction with human thioesterase and results in impairment of Nef biological functions, J VIROLOGY, 74(11), 2000, pp. 5310-5319
Authors:
Fackler, OT
Luo, W
Geyer, M
Alberts, AS
Peterlin, BM
Citation: Ot. Fackler et al., Activation of Vav by Nef induces cytoskeletal rearrangements and downstream effector functions, MOL CELL, 3(6), 1999, pp. 729-739
Authors:
Fontes, JD
Kanazawa, S
Jean, D
Peterlin, BM
Citation: Jd. Fontes et al., Interactions between the class II transactivator and CREB binding protein increase transcription of major histocompatibility complex class II genes, MOL CELL B, 19(1), 1999, pp. 941-947
Authors:
Taube, R
Fujinaga, K
Wimmer, J
Barboric, M
Peterlin, BM
Citation: R. Taube et al., Tat transactivation: A model for the regulation of eukaryotic transcriptional elongation, VIROLOGY, 264(2), 1999, pp. 245-253
Authors:
Plemenitas, A
Lu, XB
Geyer, M
Veranic, P
Simon, MN
Peterlin, BM
Citation: A. Plemenitas et al., Activation of Ste20 by Nef from human immunodeficiency virus induces cytoskeletal rearrangements and downstream effector functions in Saccharomyces cerevisiae, VIROLOGY, 258(2), 1999, pp. 271-281